Myositis
Myositis - Related Videos
09:01
Vascular Occlusion Training for Inclusion Body Myositis: A Novel Therapeutic Approach
0 Views •
Cited by 38 •
2010
The present article presents the details pertaining to the application of resistance training associated to vascular occlusion in IBM patients.
12:18
Subcutaneous Infection of Methicillin Resistant Staphylococcus Aureus (MRSA)
0 Views •
Cited by 23 •
2011
Murine skin and soft tissue infection model is utilized for assessing the virulence function of methicillin resistant Staphylococcus aureus (MRSA) and the host immunological responses. Here, we presented a subcutaneous infection model for skin and soft tissue infection.
10:04
Imaging Amyloid Tissues Stained with Luminescent Conjugated Oligothiophenes by Hyperspectral Confocal Microscopy and Fluorescence Lifetime Imaging
0 Views •
Cited by 27 •
2017
Amyloid deposition is a hallmark of different diseases and afflicts many different organs. This paper describes the application of luminescent conjugated oligothiophene fluorescence staining in combination with fluorescence microscopy techniques. This staining method represents a powerful tool for detection and exploration of protein aggregates in both clinical and scientific setups.
FAQs
In immune-mediated forms, an abnormal immune response targets muscle fibers. Inflammatory cells then infiltrate the tissue, contributing to muscle-fiber injury and impaired muscle performance. This process helps explain why weakness may progress and why patients can develop pain and reduced physical function. It also provides the biological basis for assessing both symptoms and laboratory evidence.
Creatine kinase release is a measurable consequence of muscle injury, not simply a symptom. When skeletal muscle fibers are damaged, this enzyme can enter the blood, allowing clinicians to use enzyme testing as part of the diagnostic assessment. Results are interpreted alongside clinical findings and other investigations rather than serving as the sole basis for identifying myositis.
Myositis does not always arise from the same mechanism. Some cases reflect an abnormal immune response, whereas infections, medications, or other conditions can also cause muscle inflammation. Identifying this context matters because management may require treating an underlying cause instead of relying only on approaches directed at immune activity.
Diagnostic evaluation combines symptoms with creatine kinase and other muscle-enzyme testing, autoantibody analysis, electromyography, and magnetic resonance imaging. Clinicians may also use a muscle biopsy in some cases. Using several sources of evidence helps relate the patient’s functional problems to muscle injury and inflammation, supporting a more informed assessment than any single test alone.
Treatment may include corticosteroids or other immunosuppressive therapy when abnormal immune activity contributes to the illness. If infection, medication exposure, or another condition is responsible, management also addresses that underlying cause. This combination allows care to target both the inflammatory process and the factor that may be sustaining muscle injury.
Rehabilitation helps preserve mobility and strength while clinicians manage the muscle inflammation and its underlying cause. This is important because myositis can produce progressive weakness, pain, and reduced physical function. Including rehabilitation in the care plan focuses on maintaining practical movement and physical capacity, rather than relying on medical treatment alone.